Genomenon, Inc

Genomenon provides a genomic evidence platform that aggregates, indexes, and curates published literature and clinical data at the gene and variant level to deliver actionable evidence for diagnosis and precision medicine. Its tools (including the Mastermind literature- intelligence offering) align variant interpretation with ACMG/AMP standards to help clinical diagnostic labs, researchers, and biopharma accelerate variant classification, biomarker discovery, and treatment decisions. The company emphasizes comprehensive, up-to-date literature mining and evidence tracking to improve confidence and speed in genomic decision-making for rare disease and cancer.